OpGen

OPGN NASDAQ
0.5000
+0.0579
+13.10%
盘后: 0.4800 -0.02 -4.00% 17:17 05/20 EDT
开盘
0.4300
昨收
0.4421
最高
0.5000
最低
0.4119
成交量
17.51万
成交均量(3M)
30.45万
52周最高
2.900
52周最低
0.3600
换手率
0.99%
市值
882.29万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供OpGen OPGN股票价格,OpGen股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.
展开 >

最近浏览

名称
价格
涨跌幅